Drawing for PTX NEEDLE FREE PEPTIDE TOXIN

USPTO serial 90360018

PTX NEEDLE FREE PEPTIDE TOXIN

Reviewed by CopyMark Law Group

Reg. 7135239Status 700Registered
Filing date
Status date
Registration date
Aug 15, 2023
Examiner
ALI, STEPHANIE MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PTX NEEDLE FREE PEPTIDE TOXIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miriam D. Trudell

Miriam D. Trudell Davis Graham & Stubbs LLC3400 Walnut Street, Suite 700Denver, CO 80205United States

Goods and services

ClassDescriptionStatusFirst use
001Protein for use in the manufacture of cosmetics; biochemical additives for use in the manufacture of cosmeticsACTIVE—
003Cosmetic preparations for body care; cosmetics for golf; cosmetics for massage; make-up; cosmetic preparations for protecting the skin from the sun's rays; antiperspirants; deodorants for personal use; non-medicated antiperspirants; cosmetic preparations for the care of mouth and teeth; functional cosmetics; multi-functional shampoo; anti-aging cosmetic preparations; eye make-up; eye wrinkle removing creams; cosmetic preparations for the hair and scalp; cosmetics for hiking; skin lotions; pores tightening mask packs used as cosmetics; face and body lotions; skin care lotions; beauty care cosmetics; cosmetics for animals; cosmetics containing vitamin; cosmetics using biotechnology; sun block cosmetics; sunscreen preparations; cosmetic preparations for eyelashes; phytocosmetic preparations; after-sun creams and preparations in the nature of oils, creams, and powders; cosmetics for children; cosmetics for personal use; anti-wrinkle creams; wrinkle removing skin care preparations; teeth whitening preparations; wrinkle-minimizing cosmetic preparations for topical facial use; skin whitening preparations; skin whitening creams; cosmetic preparations for skin renewal; eyebrow cosmetics; cosmetics; cosmetic preparations for skin care; cosmetics for use on the skin; non-medicated toilet preparations, namely, toilet water, toilet soap, and toilet cleaning liquidACTIVE—
005Pharmaceutical preparations for treating sensory organ disorders; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for treating halitosis; pharmaceutical preparations for the treatment of musculoskeletal disorders; muscle relaxants; preparations for the treatment of muscle fatigue; pharmaceutical preparations for treating chloasma; anti-cough drops; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for hyperhidrosis; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents for treating physically caused lesions; pharmaceutical preparations for treating dandruff; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for treating sunburns; medicines for treating intestinal disorders; pharmaceutical preparations for treating sports injuries; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of heart rhythm disorders; cardiovascular pharmaceuticals; pharmaceutical preparations for treating malignant tumours; ophthalmic muscle relaxants; ophthalmic preparations; pharmaceutical preparations for the prevention of allergies; nasal spray for the treatment of allergies; anti-allergy sprays; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for treating allergic rhinitis and asthma; allergy relief medication; allergy capsules; allergy medications; allergy tablets; pharmaceutical preparations for treating allergies; pharmaceutical preparations and compositions for the treatment and prevention of cancer; compounds for treating cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pre-filled syringes filled with muscle relaxants for medical purposes; pre-filled syringes filled with skin treatment preparations for medical purposes; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for the treatment of auto-immune diseases; autonomic drugs for medical purposes; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for central nerve treatment; preparations for the treatment of asthma; therapeutic drugs and agents; pharmaceutical preparations for treating epidermal problems; medicated preparations for skin treatment being pharmaceutical preparations for the treatment of damaged skin and tissue; antiallergic medicines; pharmaceutical preparations for the treatment of hormonal disorders; preparations for the suppression of hormones; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for chemical disorder treatmentACTIVE—
010Esthetic facial massage apparatus for skin whitening effect; medical apparatus for skin wrinkle removal with LED light; medical apparatus and instruments for skin improvement with LED light; medical apparatus for strengthening muscles of the pelvic floor; medical apparatus and instruments for treating osteoarthritis and osteoporosis; apparatus for the electrical stimulation of groups of muscles; apparatus for the therapeutic toning of the muscles for medical rehabilitative purposes; medical apparatus for hyperhidrosis treatment; medical skin enhancement apparatus using lasers; machines and apparatus for hair growth functional scalp treatments; medical apparatus and instruments for plastic surgery; nerve muscle stimulators for skin treatment and skin rejuvenation; medical apparatus and instruments for ophthalmic use; medical apparatus and instruments for acne treatment, other than for dental purposes; medical apparatus and instruments for cartilage restoration; medical apparatus and instruments for use in surgery, namely, medical apparatus and instruments for treatment of neuromuscular diseases and disorders, namely, myoclonus, hemifacial spasms, spasmodic torticollis, anal fissures, blepharospasm, facial spasms, cerebral palsy, strabismus, temporomandibular disorders, neuralgia, myalgia, overactive bladder, urge urinary incontinence, dystonia, hyperhidrosis and osmidrosis, which are used for medical treatment using the pharmaceuticals of a peptide exhibiting botulinum toxin-like activity; high frequency apparatus for medical use for treating skin conditions; electronic muscle stimulators for medical purposes for skin treatment and skin rejuvenation; wrinkle removal apparatus for medical purposes; dermal filler implants of artificial material; otolaryngological medical apparatus and instruments; artificial muscle for skin treatment and skin rejuvenation; medical apparatus and instruments relating to neurovegetative reactivity; apparatus for electrical muscle stimulation; transcutaneous electrical muscle stimulators; skin regeneration therapy apparatus for stimulating wound repair and skin regeneration, namely, wound healing devices using moving arrays of hypodermic and sterile surgical needles; medical apparatus for skin wrinkle removal; medical apparatus and instruments for the treatment of skin; all of the aforementioned goods excluding stentsACTIVE—
035Wholesale store services featuring medical apparatus and instruments for skin treatment and skin rejuvenation, other than for dental purposes; retail store services featuring medical apparatus and instruments for skin treatment and skin rejuvenation, other than for dental purposes; commercial intermediary services, namely, distributorship services in the field of medical apparatus and instruments for skin treatment and skin rejuvenation other than for dental purposes; comprehensive shopping mall services, namely, online retail store services featuring shoes, wide variety of consumer goods of others by internet; business intermediary services, namely, mail order services featuring magazines, clothing, jewelry by telecommunications; wholesale store services featuring peptides for use in the manufacture of cosmetics; retail store services featuring peptides for use in the manufacture of cosmetics; commercial intermediary services, namely, distributorship services in the field of peptides for use in the manufacture of cosmetics; wholesale store services featuring biochemical additives for use in the manufacture of cosmetics; retail store services featuring biochemical additives for use in the manufacture of cosmetics; commercial intermediary services, namely, distributorship services in the field of biochemical additives for use in the manufacture of cosmetics; wholesale store services featuring cosmetics; retail store services featuring cosmetics; commercial intermediary services, namely, distributorship services in the field of cosmetics; wholesale store services featuring pharmaceutical and veterinary preparations; retail store services featuring pharmaceutical and veterinary preparations; commercial intermediary services, namely, distributorship services in the field of pharmaceutical and veterinary preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 14, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 14, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 14, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 15, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 15, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 10, 2023TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jul 10, 2023OP.TOPPOSITION TERMINATED NO. 999999—
Jul 10, 2023OP.DOPPOSITION DISMISSED NO. 999999—
Feb 21, 2023OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 22, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 23, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 23, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 3, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 21, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
May 20, 2022ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
May 20, 2022PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
May 16, 2022APETASSIGNED TO PETITION STAFF—
Apr 22, 2022TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Feb 15, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 21, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 21, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 1, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 18, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 12, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 30, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 12, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Aug 12, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 12, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 12, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 23, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 23, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 23, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 23, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 23, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 12, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2021DOCKASSIGNED TO EXAMINER—
Feb 11, 2021MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 10, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 8, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance